Page last updated: 2024-08-17

levodopa and jaw

levodopa has been researched along with jaw in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's1 (12.50)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jeste, DV; Karson, CN; LeWitt, PA; Wyatt, RJ1
Hammerstad, JP; Robertson, LT1
Betz, AJ; Bibbiani, F; Chase, TN; Davis, RE; Kielaite, A; Salamone, JD; Vanover, KE; Weber, SM; Weiner, DM1
Ballero, M; Kasture, S; Longoni, R; Morelli, M; Pinna, A; Pontis, S; Schintu, N; Simola, N; Spina, L1
Cristalli, G; Morelli, M; Pinna, A; Pontis, S; Schintu, N; Simola, N; Tronci, E; Volpini, R1
Burchiel, KJ; Carlson-Kuhta, P; Hogarth, P; Horak, FB; Robertson, LT; St George, RJ1
LeDoux, MS; Pfeiffer, RF1
Amernik, K; Gołąb-Janowska, M; Honczarenko, K; Nowacki, P; Pawlukowska, W; Rotter, I; Safranow, K1

Trials

2 trial(s) available for levodopa and jaw

ArticleYear
Jaw movement dysfunction related to Parkinson's disease and partially modified by levodopa.
    Journal of neurology, neurosurgery, and psychiatry, 1996, Volume: 60, Issue:1

    Topics: Antiparkinson Agents; Electromagnetic Fields; Electromyography; Female; Humans; Jaw; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease

1996
Site of deep brain stimulation and jaw velocity in Parkinson disease.
    Journal of neurosurgery, 2011, Volume: 115, Issue:5

    Topics: Aged; Antiparkinson Agents; Biomechanical Phenomena; Combined Modality Therapy; Deep Brain Stimulation; Deglutition Disorders; Double-Blind Method; Female; Globus Pallidus; Humans; Jaw; Levodopa; Male; Middle Aged; Parkinson Disease; Speech Disorders; Subthalamic Nucleus; Treatment Outcome

2011

Other Studies

6 other study(ies) available for levodopa and jaw

ArticleYear
A comparison of two iatrogenic dyskinesias.
    The American journal of psychiatry, 1983, Volume: 140, Issue:11

    Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Extremities; Facial Muscles; Female; Humans; Iatrogenic Disease; Jaw; Levodopa; Male; Middle Aged; Parkinson Disease; Tongue

1983
A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model.
    Pharmacology, biochemistry, and behavior, 2008, Volume: 90, Issue:4

    Topics: Animals; Data Interpretation, Statistical; Dopamine Agents; Dyskinesia, Drug-Induced; Jaw; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Piperidines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Tremor; Urea

2008
Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease.
    Neurotoxicity research, 2009, Volume: 15, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Antiparkinson Agents; CD11b Antigen; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Jaw; Levodopa; Locomotion; Male; Mice; Mice, Inbred C57BL; Movement; Mucuna; Neuroprotective Agents; Oxidopamine; Parasympathomimetics; Parkinson Disease; Phytotherapy; Rats; Rats, Sprague-Dawley; Seeds; Sympatholytics; Tacrine; Time Factors; Vibrissae

2009
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug.
    Neuropharmacology, 2010, Volume: 58, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenine; Animals; Antiparkinson Agents; Autoradiography; Behavior, Animal; Brain Chemistry; CD11b Antigen; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Early Growth Response Protein 1; Gene Expression Regulation; Jaw; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Movement; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Psychomotor Performance; Pyrimidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rotarod Performance Test; Time Factors; Triazoles; Vibrissae

2010
Levodopa-induced lateral jaw deviation dystonia.
    Parkinsonism & related disorders, 2015, Volume: 21, Issue:7

    Topics: Aged; Dystonia; Female; Humans; Jaw; Levodopa

2015
Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease.
    Neurologia i neurochirurgia polska, 2015, Volume: 49, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Articulation Disorders; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Jaw; Levodopa; Lip; Male; Middle Aged; Parkinson Disease; Phonation; Phonetics; Range of Motion, Articular; Reflex, Abnormal; Respiration; Severity of Illness Index

2015